[Studies of isolated organisms from otorhinolaryngological infections and their susceptibilities to macrolide antibiotics]. 1985

S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura

To study current situation of pathogenic bacteria and their drug resistance to macrolide antibiotics in the otorhinolaryngological infections, 609 strains diagnosed as pathogen derived from 463 patients were collected from cohospitals or institutions during the period of 1980-1983. The results obtained were as follows: Gram-positive cocci (GPC) was dominant (410 strains) and major species were S. aureus (135 strains), S. pneumoniae (81 strains), S. epidermidis (68 strains) and S. pyogenes (65 strains). In Gram-negative bacteria giving 147 strains and 43 strains, of anaerobes prevailing species were H. influenzae, P. aeruginosa and Peptostreptococcus spp. Representative species in the diseases were S. aureus (26.6%), S. epidermidis (24.5%), and P. aeruginosa (12.8%) in acute otitis media, S. aureus (34.4%), S. epidermidis (17.7%) and P. aeruginosa (14.6%) in acute exacerbation of chronic otitis media, S. epidermidis (17.0%), S. aureus (16.1%) and H. influenzae (13.4%) in acute paranasal sinusitis, S. pyogenes (29.1%), S. pneumoniae (19.6%) and S. aureus (15.1%) in acute tonsillitis. Although most of isolates were susceptible to macrolides, 62 resistant strains to macrolides were found in 501 strains and the resistant rates were 26.7% in S. aureus, 23.1% in S. epidermidis and 6.5% in S. pyogenes. The resistant pattern was somewhat different against each macrolides, resistant strains giving over 100 micrograms/ml in MIC were 55/62 in erythromycin, 35/62 in josamycin and midecamycin and 7/62 in TMS-19-Q, a new macrolide.

UI MeSH Term Description Entries
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D010038 Otorhinolaryngologic Diseases Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases. Otolaryngologic Diseases,ENT Diseases,Otolaryngological Diseases,Otorhinolaryngologic Disease,Otorhinolaryngological Disease,Disease, ENT,Disease, Otolaryngologic,Disease, Otolaryngological,Disease, Otorhinolaryngologic,Disease, Otorhinolaryngological,Diseases, ENT,Diseases, Otolaryngologic,Diseases, Otolaryngological,Diseases, Otorhinolaryngologic,Diseases, Otorhinolaryngological,ENT Disease,Otolaryngologic Disease,Otolaryngological Disease,Otorhinolaryngological Diseases
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013212 Staphylococcus epidermidis A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.
D015644 Miocamycin A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections. Miokamycin,Ponsinomycin,9,3''-Di-O-Acetylmidecamycin,9,3''-Diacetylmidecamycin,Miocamycine,Myocamicin,PM-88908,9,3'' Di O Acetylmidecamycin,9,3'' Diacetylmidecamycin,PM 88908,PM88908

Related Publications

S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
December 1990, The Japanese journal of antibiotics,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
January 1983, The Journal of antimicrobial chemotherapy,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
February 2006, The Japanese journal of antibiotics,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
February 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
November 1963, Antibiotiki,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
November 2012, The Journal of infection,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
January 2006, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
February 1987, The British journal of oral & maxillofacial surgery,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
July 1989, Mikrobiyoloji bulteni,
S Baba, and H Kinoshita, and Y Mori, and K Suzuki, and J Shimada, and S Kawamura, and R Sugita, and Y Fujimaki, and B Sanbe, and S Ogura
October 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!